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Background: Following the 2009 H1N1 influenza pandemic, obesity was shown to be 
associated with severe influenza outcomes. It remains unclear whether obesity was a 
risk factor for milder influenza- like illness (ILI).
Objectives: To determine whether obesity was associated with an increased risk of 
self- reported ILI during the 2009 H1N1 influenza pandemic using Health Survey for 
England (HSE) 2010 cross- sectional data.
Methods: This study used HSE data collected from English households between Janu-
ary and December 2010. Weight and height measurements were taken by trained 
fieldworkers to determine obesity. ILI was defined as a positive response to the ques-
tion “Have you had a flu- like illness where you felt feverish and had a cough or sore 
throat?” with illness occurring between May and December 2009. Multivariable logis-
tic regression was used to evaluate the association between obesity and ILI.
Results: The study comprised 8407 participants (6984 adults, 1436 children), among 
whom 24.7% (95% CI: 23.6–25.9) were classified as obese. Of obese participants, 
12.8% (95% CI: 11.1–14.8) reported ILI compared to 11.8% (95% CI: 10.8–12.8) of 
non- obese participants. The adjusted OR for ILI associated with obesity was 1.16 
(95% CI: 0.98–1.38, P=.093). For adults and children, the adjusted ORs were 1.16 
(95% CI: 0.97–1.38, P=.101) and 1.26 (95% CI: 0.72–2.21, P=.422), respectively.
Conclusion: Household survey data showed no evidence that obesity was associated 
with an increase in self- reported ILI during the 2009 H1N1 influenza pandemic in 
England. Further studies using active prospective ILI surveillance combined with labo-
ratory reporting would reduce bias and improve accuracy of outcome measurements.
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1  | INTRODUCTION
New evidence emerged following the 2009 H1N1 influenza pan-
demic that obesity was an independent risk factor for hospitalization, 
intensive care unit admission and death in laboratory- confirmed 
influenza cases from 19 countries.1 Obesity has also been shown 
to aggravate the effect of seasonal influenza on respiratory mortal-
ity independent of the effect of comorbidities and meteorological 
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factors.2 Although obesity is associated with immune dysregulation at 
the cellular level,3,4 it remains unclear whether it is associated with 
severe influenza outcomes through increasing the risk of acquiring 
influenza infection, promoting progression to severe disease after 
infection or both.5,6
The vast majority of people with symptomatic influenza have 
mild illnesses and therefore do not seek medical attention7; rates of 
laboratory testing increase with severity of illness. Studies based on 
medical records and/or laboratory testing thus fail to capture much 
of the burden of community influenza- like illness (ILI)8 and may not 
yield insights transferable to the wider population. Studies using self- 
reported height and weight measurements to calculate body mass 
index (BMI) may be subject to recall bias and misclassification due to 
participants reporting a more socially desirable height and weight.9 
Other studies based on BMI measurements extracted from medical 
records may be limited by lack of timeliness and accuracy of BMI 
recording.
In this study, we use data from the Health Survey for England 
(HSE)10—a nationally representative population- based study in which 
obesity classification is based on weight and height measurements 
taken by trained fieldworkers—to determine whether obesity was 
associated with an increased risk of self- reported ILI during the 2009 
H1N1 influenza pandemic.
2  | METHODS
2.1 | Data source and population
The 2010 HSE data set was used for this study.11 It comprised data 
from a sample of adults aged 16+ years and children 0 to 15 years 
representative of private households in England. HSE methods are 
described elsewhere.12 All data used in our study, including detailed 
information on social and demographic characteristics, lifestyle 
behaviours, health and physical measurements such as weight and 
height, were collected during household visits by trained interviewers, 
which took place throughout the 2010 calendar year. For inclusion in 
this study, HSE participants had to have both a valid measure of obe-
sity and a valid response to the question used to identify influenza- like 
illness.
2.2 | Definition of outcome and exposure
The outcome of interest was ILI experienced during the first eight 
months of the H1N1 pandemic between May 2009 and December 
2009. The question used to identify ILI was “Since May 2009, have 
you had a flu- like illness where you felt feverish and had a cough 
or sore throat?” Permitted responses were “yes” and “no” with the 
responses “don’t know” and “refused” recoded to missing. If partici-
pants responded “yes,” they were asked to report the month and year 
of illness. Illnesses reported to occur after December 2009 were not 
included in the outcome definition.
The primary exposure, obesity, was based on BMI measure-
ments for adults aged 16 and over and on age- and sex- based 
population centiles for children aged 2–15 years. Those aged under 
two did not have height measurements so were excluded from analy-
ses. Interviewers measured height on those aged 2+ and weight for all 
participants. For participants exceeding the weight limit of the scales 
(130 kg), self- reported weights were used to calculate BMI. BMI mea-
surements considered unreliable (i.e. pregnant women, those who 
refused to be measured, measurements that were attempted but not 
obtained, measurements that were not attempted or measurements 
that were not useable) were excluded from analyses. Adult partici-
pants with a BMI 30 kg/m2 or above were classified as obese; children 
were classified as obese if their weight exceeded the 95th centile.13 
A binary variable for obesity (obese vs non- obese) was generated that 
combined results for adults and children. We also conducted two sen-
sitivity analyses: first we reclassified BMI for adults as underweight/
normal (BMI <25), overweight (BMI 25–29.999) and obese (BMI≥30), 
then removed the overweight category to compare obese with under-
weight/normal weight individuals; second, we used the waist hip ratio 
variable as an alternate measure of obesity in adults only, which was 
classified as either “not at increased risk” or “substantially increased 
risk” according to standard cut- offs.14 Only participants with a valid 
waist hip ratio measurement were included in this analysis.
2.3 | Potential confounding and effect 
modifying variables
We considered variables as potential confounders or effect modifiers 
based on findings from previous studies and consideration of plausi-
ble biological mechanisms. At individual level across the whole study 
population, we considered age, sex, ethnicity, receiving influenza vac-
cination from October 2009 (the month the pandemic vaccination 
was introduced in the UK), clinician- diagnosed asthma and season of 
interview. Information on some potential confounding variables was 
available for adults only. These included smoking status (reported 
as current smoker, ex- smoker or never smoker), frequency of alco-
hol consumption in the last 12 months, clinician diagnosis of chronic 
obstructive pulmonary disease (COPD), high blood pressure or dia-
betes and level of education achieved. The household level variables 
urbanization, household size and Index of Multiple Deprivation 2007 
(IMD2007) were also included.
2.4 | Statistical analysis
Data analysis was conducted using Stata version 13.0 (Stata 
Corporation, TX, USA). We described baseline characteristics of par-
ticipants by calculating the frequency and survey weighted percent-
age for all categories of variables of interest. Weighting was used 
to correct the distribution of household members to match popu-
lation estimates for sex/age groups and geographic region, as well 
as to correct for bias resulting from individual non- response within 
households.15 Stata’s “svy” suite of commands was used to account 
for the complex survey design. We used univariate logistic regres-
sion analysis to generate an odds ratio with 95% confidence inter-
val for the association between obesity and influenza- like illness, 
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with participants who were not obese (BMI <30 kg/m2) forming the 
baseline reference group. Univariate associations between all poten-
tial confounders and obesity and separately ILI were investigated 
through chi- squared tests and logistic regression analysis. We also 
drew a causal diagram using the programme DAGitty v 2.3 (http://
www.dagitty.net/dags.html#) to inform choice of variables for inclu-
sion in multivariable logistic regression models (see Supplementary 
material). Multivariable models were then generated: the main model 
included all theoretically relevant confounders associated with both 
outcome and exposure, for which adjustment was identified as nec-
essary using our causal diagram. Each variable added was examined 
for multicollinearity. For asthma, COPD and smoking, we generated a 
composite binary variable which was positive if any of these variables 
was positive. For each model, we examined the change in effect size 
and the Wald test P- value compared to the crude model. Potential 
effect modifiers identified based on existing literature (influenza vac-
cination, type of diabetes and age) were also evaluated using interac-
tion terms within the final logistic regression model. The Wald test 
P- value was used to assess the strength of the interaction. Analyses 
were repeated separately for adults and children. Other sensitivity 
analyses were conducted for adults only to investigate the effect of 
varying the definition of obesity. These were 1) removing the over-
weight category to compare obese individuals with normal/under-
weight individuals and 2) using waist–hip ratios in place of BMI as a 
measure of obesity.
3  | RESULTS
3.1 | Participant characteristics
Between January and December 2010, the HSE selected 8736 house-
holds, of which 90.8% met the inclusion criteria and 66% participated. 
From the core HSE sample of 10 494 participants interviewed, 2803 
participants were excluded due to non- valid BMI measurements and a 
further four because of invalid influenza- like illness responses, leaving 
8407 participants in our study (Fig. 1).
These were 6984 adults with a median age of 48 years (IQR 
35–63 years), and 1436 children with a median age of 9 years (IQR 
5–12 years). There were 3872 males and 4535 females in the data 
set. Overall, 2159 participants, a weighted percentage of 24.7% (95% 
CI: 23.6–25.9), were classified as obese. For adults, corresponding fig-
ures were 26.1% (95% CI: 24.9–27.4) compared to 17.3% (95% CI: 
1 5.2–19.7) for children. A total of 197 adults (2.8%) were morbidly 
obese (BMI >40). In total, 996 participants (12.0% [95% CI: 11.1–
13.0]) reported ILI between May and December 2009. Baseline char-
acteristics of participants presented by obesity category are shown in 
Table 1.
3.2 | Univariate analysis
Among obese participants, 12.8% (95% CI: 11.1–14.8) experienced 
ILI between May to December 2009 compared to 11.8% (95% CI: 10. 
8–12.8) of participants who were not obese. The unadjusted OR was 
1.11 (95% CI: 0.93–1.31, P- value: .241). The highest odds of report-
ing ILI were seen in the age group 25–34.9 years, and ILI was least 
reported among people aged 65 years and over. Asthma, COPD and 
current smoking were associated with an increase in ILI reporting on 
univariate analysis, while hypertension was associated with a small 
decrease. The frequency of ILI reporting also varied by interview sea-
son and was most common in spring. People with no qualifications or 
foreign/other qualifications reported less ILI than those with higher 
levels of education. Obesity was associated with age, ethnicity, influ-
enza vaccination, high blood pressure, diabetes, asthma, smoking sta-
tus in adults, alcohol consumption in adults, COPD, household size, 
IMD score and education on univariate analysis (Table 2).
3.3 | Multivariable analysis
In multivariable analysis across the whole study population (adults 
and children), the adjusted OR for the effect of obesity on likelihood 
of ILI was 1.16 (95% CI 0.98–1.38) P=.093. In an adults - only model 
with additional adjustment for highest educational qualification, the 
adjusted OR was 1.16 (95% CI 0.97–1.38) (P=.101). Similar effects 
were seen in a child- only model—adjusted OR 1.26 (95% CI 0.72–
2.21) (P=.422). There was no evidence of interaction in these models.
3.4 | Sensitivity analyses
In sensitivity analyses of adults only, removing the overweight cat-
egory (n=2627) to compare ILI reporting in obese adults (n=1908) 
with normal/underweight adults (n=2449) resulted in an adjusted OR 
of 1.14 (95% CI 0.92–1.40) P=.222. A second sensitivity analysis to 
investigate ILI reporting in adults with high waist–hip ratios (n=1979) 
compared with adults with normal waist–hip ratios (n=2932) again 
showed that there was little difference—adjusted OR 1.08 (95% CI 
0.88–1.32) (P=.472). Results of multivariable models and sensitivity 
analyses are shown in Table 3.F IGURE  1 Flow diagram of study participants
14 112
10 494
3618 dropped: not part of core HSE 
sample 
8411
2083 dropped: non-valid BMI 
measurements (including children <2 
years n = 282; pregnant women n = 114) 
8407
4 dropped: non-valid influenza-like illness 
measurement
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TABLE  1 Baseline characteristics of study population, n=8407
Variable Category
Total 
number
Number 
obese
Number 
not obese
Weighted percentage 
(95% CI)
Age group (years) Under 5 315 41 274 3.3 (2.9–3.7)
5–14.9 1108 210 898 13.0 (12.2–13.9)
16–24.9 721 90 631 12.6 (11.3–13.9)
25–34.9 989 208 781 13.6 (12.6–14.7)
35–44.9 1246 336 910 15.3 (14.4–16.3)
45–54.9 1283 400 883 14.8 (14.0–15.6)
55–64.9 1165 394 771 12.4 (11.5–13.2)
65 and over 1580 480 1100 15.1 (14.1–16.1)
Sex Male 3872 1011 2861 50.3 (49.2–51.3)
Female 4535 1148 3387 49.8 (48.7–50.8)
Ethnicity White 7515 1951 5564 87.06 (85.2–88.7)
Mixed 147 29 118 1.8 (1.4–2.3)
Asian 445 89 356 6.7 (5.5–8.1)
Black 216 67 149 3.2 (2.5–4.1)
Other 74 21 53 1.2 (0.8–1.8)
Obesity Yes 2159 2159 0 24.7 (23.6–25.88)
No 6248 0 6248 75.3 (74.1–76.4)
ILI between May and December 2009 Yes 996 270 726 12.0 (11.1–13.0)
No 7411 1889 5522 88.0 (87–88.9)
Self- reported influenza vaccination from 
October 2009
Yes 2254 737 1517 23.4 (22.3–24.6)
No 6147 1421 4726 76.6 (75.4–77.7)
High blood pressurea (adults only) Yes 1906 823 1083 23.8 (22.6–24.9)
No 5061 1083 3978 76.2 (75.1–77.4)
Diabetesa (adults only) Yes 447 239 208 5.7 (5.1–6.3)
No 6532 1667 4865 94.3 (93.7–94.9)
Asthmaa Yes 1393 390 1003 16.7 (15.8–17.7)
No 7012 1769 5243 83.3 (82.4–84.2)
Interview season Spring (March–May) 2293 579 1714 27.2 (23.7–31.0)
Summer (June–August) 2078 550 1528 24.7 (21.3–28.4)
Autumn (September–November) 2200 553 1647 26.1 (22.7–29.8)
Winter (December–February) 1836 477 1359 22.1 (19.0–25.5)
Smoking status (adults only) Current smoker 1371 336 1035 20.5 (19.3–21.9)
Ex- smoker 1886 620 1266 24.8 (23.6–26.0)
Never smoker 3705 951 2754 54.7 (53.1–56.3)
Alcohol consumption in the last 12 mo 
(adults only)
At least weekly 4041 1000 3041 57.3 (55.6–59.0)
At least monthly 950 278 672 14.2 (13.3–15.2)
At least yearly 1115 383 732 15.6 (14.5–16.7)
Not at all in last yr 855 246 609 12.9 (11.7–14.2)
COPDa (adults only) Yes 363 127 236 4.6 (4.1–5.1)
No 6614 1780 4834 95.4 (94.9–96.0)
Level of education achieved (adults only) Degree 1548 322 1226 23.2 (21.9–24.5)
School 3800 1034 2766 56.1 (54.7–57.5)
Foreign/Other 117 30 87 1.4 (1.2–1.7)
No qualification 1510 520 1179 19.4 (18.2–20.7)
(continues)
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Variable Category
Total 
number
Number 
obese
Number 
not obese
Weighted percentage 
(95% CI)
Urbanizationb Urban 3586 1056 2530 81.1 (78.4–83.4)
Town and fringes 447 139 308 9.0 (7.5–10.9)
Village, hamlet and isolated 
dwelling
482 121 361 9.9 (8.4–11.7)
Household size (persons)b One 1197 364 833 27.6 (26.0–29.2)
Two 1656 494 1162 35.7 (34.3–37.1)
Three to five 1580 433 1147 35.0 (33.6–36.6)
Six or more 82 25 57 1.8 (1.4–2.2)
IMD 2007b (least to most deprived) 0.37–8.32 1013 240 773 21.6 (19.4–24.0)
8.32 to >13.74 897 234 663 19.4 (17.6–21.4)
13.74 to >21.22 894 268 626 20.3 (18.4–22.4)
21.22 to >34.42 888 294 594 19.8 (18.0–21.8)
34.42 to>85.46 823 280 543 18.8 (16.8–21.0)
aSelf- report of clinician diagnosis.
bHousehold level variable, n=4515.
TABLE  1  (continued)
TABLE  2 Odds ratios for associations between potential confounding factors, ILI and obesity
Variable Category
OR for association 
with ILI (95% CI)
Wald 
P- value
OR for association 
with obesity (95% CI)
Wald 
P- value
Age group Under 5 1 <.0001 1 <.0001
5–14.9 0.68 (0.44–1.03) 1.44 (0.97–2.14)
16–24.9 1.11 (0.71–1.74) 0.88 (0.56–1.37)
25–34.9 1.30 (0.86–1.97) 1.64 (1.12–2.39)
35–44.9 1.18 (0.80–1.74) 2.37 (1.61–3.48)
45–54.9 0.95 (0.62–1.44) 3.08 (2.10–4.51)
55–64.9 0.92 (0.60–1.40) 3.34 (2.26–4.94)
65 and over 0.41 (0.27–0.64) 2.76 (1.87–4.06)
Sex Male 1 .326 1 .531
Female 1.07 (0.93–1.24) 0.97 (0.88–1.07)
Ethnicity White 0.52 (0.17–1.62) .520 0.73 (0.36–1.46) .025
Mixed 0.62 (0.18–2.10) 0.55 (0.24–1.25)
Asian 0.61 (0.19–1.96) 0.53 (0.25–1.13)
Black 0.40 (0.11–1.44) 0.94 (0.41–2.15)
Other 1 1
Self- reported influenza vaccination from Oct 
2009
Yes 1.02 (0.86–1.22) .804 1.67 (1.49–1.88) <.0001
No 1 1
High blood pressurea Yes 0.80 (0.68–0.96) .014 3.09 (2.74–3.49) <.0001
No 1 1
Diabetesa Yes 0.95 (0.71–1.26) .761 3.48 (2.85–4.25) <.0001
No 1 1
Asthmaa Yes 1.47 (1.24– <.0001 1.15 (1.01–1.31) .042
No 1.74) 1 1
(continues)
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4  | DISCUSSION
We found no evidence that obesity was associated with an increase 
in self- reported ILI during the 2009 H1N1 pandemic in English house-
holds using representative population data from the HSE. In our data 
set, people aged 25–35 were most likely to experience ILI and the 
over 65 age group were least likely to report ILI, consistent with other 
data from the pandemic.8 We have previously shown that ILIs report-
ed in the HSE 2010 show a similar pattern and age distribution to 
infections identified in the Flu Watch cohort study,16 although the 
overall magnitude of ILI was considerably less. The Flu Watch cohort 
was designed to estimate the community burden of ILI by collecting 
data using active weekly prospective follow- up but did not measure 
obesity.
Meta- analysis of hospitalization and death data from the 2009 
pandemic suggests that obesity is an independent risk factor for 
severe outcomes of pandemic influenza.1 Individual studies report 
similar findings for seasonal influenza.2,17,18 One case cohort study 
found that obese adults aged 20–59 years had an increased risk of 
attending outpatient clinics with ILI symptoms than those of normal 
Variable Category
OR for association 
with ILI (95% CI)
Wald 
P- value
OR for association 
with obesity (95% CI)
Wald 
P- value
Interview season Spring (March–May) 1 <.0001 1 .838
Summer (June–August) 0.69 (0.55–0.86) 1.06 (0.90–1.24)
Autumn 
(September–
November)
0.58 (0.45–0.75) 1.02 (0.86–1.21)
Winter 
(December–February)
0.95 90.75–1.21) 1.07 (0.90–1.27)
Smoking status (adults only) Current smoker 1.24 (1.02–1.50) .031 0.95 (0.81–1.13) <.0001
Ex- smoker 0.93 (0.77–1.12) 1.52 (1.33–1.74)
Never smoker 1 1
Alcohol consumption in the last 12 mo (adults 
only)
At least weekly 0.95 (0.74–1.22) .348 0.84 (0.70–1.02) <.0001
At least monthly 1.11 (0.82–1.50) 1.01 (0.80–1.27)
At least yearly 1.11 (0.83–1.49) 1.29 (1.05–1.58)
Not at all in the last 
year
1 1
COPDa (adults only) Yes 1.41 (1.04–1.91) .026 1.54 (1.20–1.97) .0007
No 1 1
Level of education achieved (adults only) Degree 1 <.0001 1 <.0001
School 1.00 (0.82–1.22) 1.41 (1.20–1.66)
Foreign/Other 0.32 (0.14–0.75) 1.34 (0.86–2.09)
No qualification 0.60 (0.46–0.78) 1.97 (1.65–2.35)
Urbanizationb Urban 1 .195 1 .249
Town and fringes 0.96 (0.70–1.32) 1.13 (0.93–1.38)
Village, hamlet and 
isolated dwelling
0.76 (0.57–1.02) 0.92 (0.77–1.10)
Household size (persons)b One 1 .036 1 <.0001
Two 0.74 (0.60–0.92) 0.93 (0.79–1.09)
Three to five 0.83 (0.67–1.04) 0.69 (0.59–0.80)
Six or more 1.08 (0.66–1.77) 0.61 (0.41–0.91)
IMD 2007b 0.37–8.32 1 .441 1 <.0001
8.32 to >13.74 0.92 (0.72–1.19) 1.08 (0.88–1.32)
13.74 to >21.22 1.08 (0.84–1.39) 1.26 (1.05–1.52)
21.22 to >34.42 1.18 (0.92–1.51) 1.43 (1.19–1.72)
34.42 to >85.46 (most 
deprived)
1.08 (0.81–1.43) 1.56 (1.27–1.90)
aSelf- report of clinician diagnosis.
bHousehold level variable, n=4515.
TABLE  2  (continued)
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weight in the influenza seasons 2004/5 and the 2009 pandemic.19 An 
Australian population health survey showed that people with obesity 
were more likely to report ILI during July to September 2009 than peo-
ple of normal weight.20 Few other studies, though, have investigated 
the role of obesity as a risk factor for mild ILI in the community.
Strengths of this study include the large nationally representa-
tive sample and the use of professionally obtained height and weight 
measurements for classifying obesity. This may have avoided inac-
curacies associated with self- reported BMI such as underestimation 
due to social stigma and social desirability which have affected other 
studies using self- reporting.17,18 The similar results obtained in sensi-
tivity analyses using waist–hip ratio to classify obesity and removing 
the overweight category to compare obese individuals with normal/
underweight individuals further strengthen our findings. The use of 
self- reported ILI as an outcome measure may have captured the com-
munity prevalence more accurately than clinical surveillance studies 
based on those who seek medical care,21,22 and it also avoided issues 
with timing and accuracy of laboratory tests. Nonetheless, using HSE 
data on ILI had some limitations. HSE questions only asked about one 
episode of illness so multiple episodes would have been missed. Recall 
bias, particularly in interviews taking place many months after illness 
due to the rolling nature of the survey, may have affected ILI report-
ing.16 Mild symptoms, which were a typical feature of many infections 
in the 2009 influenza pandemic, may not have been attributed to ILI 
by participants. There is also a risk that media coverage of the pan-
demic may have resulted in a change in reporting behaviour among 
participants. Although validating our measure of ILI against other 
definitions such as the European Centre for Disease Prevention and 
Control definition would have enhanced results, it was not possible 
with the limited ILI data collected in the HSE. The HSE does, howev-
er, provide a unique breadth of insight into population- level general 
health and social issues, which exceeds that of most other sources, 
and allows consideration of a range of potential confounding factors.
The use of weighting in analyses helped to ensure that partici-
pants selected were representative of the population at both regional 
and national level. There may, however, have been residual selection 
biases: institutionalized populations, those with mental disabilities, 
children without parental consent and those who could not speak 
English were excluded from participation. As institutionalized pop-
ulations are more likely to be older and are potentially less healthy 
than those living as private residents in England, they may be more 
likely to experience ILI. Exclusion of those with mental disabilities or 
children less than 16 years without parental consent may also have 
underestimated the frequency of ILIs and may limit generalizability of 
results to these groups. It was not possible to examine the interac-
tion between pregnancy and obesity as risk factors for ILI. Pregnant 
women were excluded due to difficulties with interpreting BMI in this 
group, but they only made up 0.65% of the HSE 2010 core population 
from which our sample was drawn.
Overall in 2010, data from our study showed that around a quar-
ter (24.7%) of the English population was obese (BMI >30 kg/m2). 
Among those who were obese, 12.8% experienced ILI between May 
and December 2009. Although this study found no evidence that obe-
sity was associated with an increase in likelihood of self- reporting ILI 
symptoms during the 2009 H1N1 pandemic in England, there is some 
suggestion from other studies that a higher proportion of obese peo-
ple who become infected with influenza progress to severe disease 
than those with a normal weight.1,2 While the mechanisms of associ-
ation between obesity and severe influenza are not well understood, 
murine models provide some evidence that obesity may delay innate 
immune activation in response to influenza infection and therefore 
lead to a suboptimal adaptive immune response.23 Obese people may 
therefore be a sensible target group for antiviral drugs when they do 
develop ILI. There are also unanswered questions about the use of 
influenza vaccine in obesity. In October 2014, the Joint Committee on 
Vaccination and Immunisation in the United Kingdom recommended 
influenza vaccination to reduce the chances of complications following 
influenza infections for those who are morbidly obese (BMI >40 kg/
m2).24 This has not yet been adopted into the UK vaccine schedule, 
so currently, people with BMI >40 kg/m2 are only vaccinated if they 
meet other vaccine criteria such as diabetes.24,25 Further studies of 
the role of obesity in a larger population, preferably using active pro-
spective surveillance of ILI combined with laboratory reporting would 
help to minimize recall bias and improve outcome measurements. This 
TABLE  3 Effect estimates of total population and subpopulation analysis on the association between obesity and ILI
Participants Obesity category Crude OR (95% CI) Wald test P- value Adjusted ORa (95% CI) Wald test P- value
All Non- obese 1 – 1 –
Obese 1.11 (0.93–1.31) .241 1.16 (0.98–1.38) .093
Adults only Non- obese 1 – 1 –
Obese 1.07 (0.91–1.27) .417 1.16 (0.97–1.38) .101
Children only Non- obese 1 – 1 –
Obese 1.23 (0.71–2.15) .461 1.26 (0.72–2.21) .422
Sensitivity analysis 1 (adults 
only, excluding overweight 
category)
Non- obese 1 – 1 –
Obese 1.03 (0.85–1.25) .735 1.14 (0.92–1.40) .222
Sensitivity analysis 1 (adults 
only, using waist–hip ratio)
Non- obese 1 – 1 –
Obese 0.88 (0.73–1.06) .167 1.08 (0.88–1.32) .472
aAdjusted for age, sex, household size, composite lung variable (asthma, COPD, smoking) and, for adult model only, education.
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research will be invaluable for informing healthcare planning, guiding 
targeting of resources and informing governments to ensure a propor-
tionate response to future influenza pandemics.
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